Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Jun-23 6:14 PM View:  | MiMedx Group, Inc. (MDXG) | 13-Jun-23 | Grant | 35,354 | $4.95 | $175,002.00 | 43% 81.67K to 117.02K | |
| 13-Jun-22 6:32 PM View: | MiMedx Group, Inc. (MDXG) | 07-Jun-22 | Grant | 44,191 | $3.96 | $174,996.00 | 118% 37.48K to 81.67K | |
| 28-May-21 2:26 PM View: | MiMedx Group, Inc. (MDXG) | 27-May-21 | Grant | 17,056 | $10.26 | $174,995.00 | 84% 20.42K to 37.48K | (< 1%) |
| 29-Apr-21 4:30 PM View: | MiMedx Group, Inc. (MDXG) | 28-Apr-21 | Grant | 20,423 | $10.71 | $218,730.00 | 100% 0 to 20.42K | 0% |
| 15-May-20 6:39 PM View: | Revance Therapeutics, Inc. (RVNC) | 14-May-20 | Grant | 6,000 | -- | -- | 57% 10.5K to 16.5K | |
| 10-May-19 9:05 PM View: | Revance Therapeutics, Inc. (RVNC) | 09-May-19 | Grant | 4,500 | -- | -- | 75% 6.0K to 10.5K | |
| 28-Nov-18 7:52 PM View: | Corium International, Inc. (CORI) | 27-Nov-18 | Disposition | 34,203 | $12.50 | $427,538.00 | (100%) 34.2K to 0 | (1%) |
| 11-May-18 8:28 PM View: | Revance Therapeutics, Inc. (RVNC) | 10-May-18 | Grant | 3,000 | -- | -- | 100% 3.0K to 6.0K | |
| 16-Mar-18 8:35 PM View: | Revance Therapeutics, Inc. (RVNC) | 16-Mar-18 | Option Exercise | 5,333 | $2.55 | $13,599.10 | 178% 3.0K to 8.33K | |
| 16-Mar-18 8:35 PM View: | Revance Therapeutics, Inc. (RVNC) | 16-Mar-18 | Market Option Sale | 5,333 | $31.51 | $168,046.00 | (64%) 8.33K to 3.0K | 12% |
| 21-Aug-17 6:07 PM View: | Corium International, Inc. (CORI) | 21-Aug-17 | Option Exercise | 33,064 | $2.12 | $70,128.70 | 2903% 1.14K to 34.2K | |
| 12-May-17 7:49 PM View: | Revance Therapeutics, Inc. (RVNC) | 11-May-17 | Grant | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 30-Mar-15 5:36 PM View: | Corium International, Inc. (CORI) | 27-Mar-15 | Option Exercise | 1,139 | $0.20 | $230.08 | 100% 0 to 1.14K | |
| 11-Feb-14 2:29 PM View: | Revance Therapeutics, Inc. (RVNC) | 11-Feb-14 | Conversion | 444,246 | -- | -- | 100% 0 to 444.25K | |
| 11-Feb-14 2:29 PM View: | Revance Therapeutics, Inc. (RVNC) | 11-Feb-14 | Exercise (in-the money or at-the-money) | 12,839 | -- | -- | 3% 444.25K to 457.08K |